A drug allosterically inhibits activity of histone deacetylase. the most likely effect of exposure to this drug with be increase in: efficacy.
The use of histone deacetylase inhibitor therapy as adjuvant therapy or monotherapy has the potential to be beneficial in the treatment of cancer. Multiple cancers have been studied with histone deacetylase inhibitor. use, with varying degrees of success. With only limited success in clinical studies, in vitro research has revealed the anticancer activity of histone deacetylase inhibitor to be the most promising. In general, combining histone deacetylase inhibitor therapy with conventional chemotherapeutic drugs maximizes its efficacy. Less hazardous exposure and greater effectiveness are benefits of utilizing histone deacetylase inhibitor as adjunct drugs.
To learn more about Histone deacetylase click here:
https://brainly.com/question/15868643
#SPJ4